Follow
Nicholas P J Day
Nicholas P J Day
Professor of Tropical Medicine, University of Oxford
Verified email at ndm.ox.ac.uk
Title
Cited by
Cited by
Year
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis
CJL Murray, KS Ikuta, F Sharara, L Swetschinski, GR Aguilar, A Gray, ...
The Lancet 399 (10325), 629-655, 2022
61502022
Artemisinin Resistance in Plasmodium falciparum Malaria
AM Dondorp, F Nosten, P Yi, D Das, AP Phyo, J Tarning, KM Lwin, F Ariey, ...
New England journal of medicine 361 (5), 455-467, 2009
40232009
Multilocus Sequence Typing for Characterization of Methicillin-Resistant and Methicillin-Susceptible Clones ofStaphylococcus aureus
MC Enright, NPJ Day, CE Davies, SJ Peacock, BG Spratt
Journal of clinical microbiology 38 (3), 1008-1015, 2000
37772000
Spread of artemisinin resistance in Plasmodium falciparum malaria
EA Ashley, M Dhorda, RM Fairhurst, C Amaratunga, P Lim, S Suon, ...
New England Journal of Medicine 371 (5), 411-423, 2014
23562014
Evolution of MRSA during hospital transmission and intercontinental spread
SR Harris, EJ Feil, MTG Holden, MA Quail, EK Nickerson, N Chantratita, ...
Science 327 (5964), 469-474, 2010
12612010
Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance
MTG Holden, EJ Feil, JA Lindsay, SJ Peacock, NPJ Day, MC Enright, ...
Proceedings of the National Academy of Sciences 101 (26), 9786-9791, 2004
11982004
Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial
AM Dondorp, CI Fanello, ICE Hendriksen, E Gomes, A Seni, ...
The Lancet 376 (9753), 1647-1657, 2010
11032010
Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study
AP Phyo, S Nkhoma, K Stepniewska, EA Ashley, S Nair, R McGready, ...
The Lancet 379 (9830), 1960-1966, 2012
10592012
Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial.
A Dondorp, F Nosten, K Stepniewska, N Day, N White
Lancet (London, England) 366 (9487), 717-725, 2005
9902005
Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis
D Limmathurotsakul, N Golding, DAB Dance, JP Messina, DM Pigott, ...
Nature microbiology 1 (1), 1-5, 2016
9052016
Artemisinin resistance: current status and scenarios for containment
AM Dondorp, S Yeung, L White, C Nguon, NPJ Day, D Socheat, ...
Nature Reviews Microbiology 8 (4), 272-280, 2010
8272010
Neurological manifestations of dengue infection
T Solomon, NM Dung, DW Vaughn, R Kneen, B Raengsakulrach, ...
The Lancet 355 (9209), 1053-1059, 2000
8082000
How Clonal Is Staphylococcus aureus?
EJ Feil, JE Cooper, H Grundmann, DA Robinson, MC Enright, T Berendt, ...
Journal of bacteriology 185 (11), 3307-3316, 2003
7972003
Virulent Combinations of Adhesin and Toxin Genes in Natural Populations of Staphylococcus aureus
SJ Peacock, CE Moore, A Justice, M Kantzanou, L Story, K Mackie, ...
Infection and immunity 70 (9), 4987-4996, 2002
7962002
Artesunate combinations for treatment of malaria: meta-analysis
International Artemisinin Study Group
The Lancet 363 (9402), 9-17, 2004
7322004
Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei
WJ Wiersinga, T Van der Poll, NJ White, NP Day, SJ Peacock
Nature Reviews Microbiology 4 (4), 272-282, 2006
7102006
Genetic architecture of artemisinin-resistant Plasmodium falciparum
O Miotto, R Amato, EA Ashley, B MacInnis, J Almagro-Garcia, ...
Nature genetics 47 (3), 226-234, 2015
6392015
Recombination within natural populations of pathogenic bacteria: short-term empirical estimates and long-term phylogenetic consequences
EJ Feil, EC Holmes, DE Bessen, MS Chan, NPJ Day, MC Enright, ...
Proceedings of the National Academy of Sciences 98 (1), 182-187, 2001
6262001
The prognostic and pathophysiologic role of pro-and antiinflammatory cytokines in severe malaria
NPJ Day, TT Hien, T Schollaardt, PP Loc, LV Chuong, TT Hong Chau, ...
The Journal of infectious diseases 180 (4), 1288-1297, 1999
5621999
A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis
CC Khor, SJ Chapman, FO Vannberg, A Dunne, C Murphy, EY Ling, ...
Nature genetics 39 (4), 523-528, 2007
5552007
The system can't perform the operation now. Try again later.
Articles 1–20